Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 503

1.

Prospective in silico study of the feasibility and dosimetric advantages of MRI-guided dose adaptation for human papillomavirus positive oropharyngeal cancer patients compared with standard IMRT.

Mohamed ASR, Bahig H, Aristophanous M, Blanchard P, Kamal M, Ding Y, Cardenas CE, Brock KK, Lai SY, Hutcheson KA, Phan J, Wang J, Ibbott G, Gabr RE, Narayana PA, Garden AS, Rosenthal DI, Gunn GB, Fuller CD; MD Anderson MRLinac Development Working Group.

Clin Transl Radiat Oncol. 2018 May 5;11:11-18. doi: 10.1016/j.ctro.2018.04.005. eCollection 2018 Jun.

2.

Multiple episodes of 1080 (sodium monofluoroacetate) intoxication in a California calf-raising operation.

Adaska JM, Rimoldi G, Blanchard PC, Champagne J, Poppenga RH, Mostrom M.

J Vet Diagn Invest. 2018 Jul 1:1040638718781435. doi: 10.1177/1040638718781435. [Epub ahead of print]

PMID:
29973111
3.

Smoking impact on HPV driven head and neck cancer's oncological outcomes?

Mirghani H, Leroy C, Chekourry Y, Casiraghi O, Aupérin A, Tao Y, Nguyen F, Caroline E, Breuskin I, Plana AM, Hartl D, Janot F, Temam S, Gorphe P, Blanchard P.

Oral Oncol. 2018 Jul;82:131-137. doi: 10.1016/j.oraloncology.2018.05.007. Epub 2018 May 26.

PMID:
29909887
4.

[Prostate brachytherapy: New techniques, new indications].

Blanchard P, Graff-Cailleaud P, Bossi A.

Cancer Radiother. 2018 Jun;22(4):352-358. doi: 10.1016/j.canrad.2017.11.012. Epub 2018 May 30. Review. French.

PMID:
29858134
5.

Treating Metastatic Prostate Cancer With Local Therapies: Is It Still Wishful Thinking?

Bibault JE, Blanchard P.

J Clin Oncol. 2018 Jun 1:JCO2017775429. doi: 10.1200/JCO.2017.77.5429. [Epub ahead of print] No abstract available.

PMID:
29856690
6.

Pharmacological modulation of radiation-induced oral mucosal complications.

Bockel S, Vallard A, Lévy A, François S, Bourdis M, Le Gallic C, Riccobono D, Annede P, Drouet M, Tao Y, Blanchard P, Deutsch É, Magné N, Chargari C.

Cancer Radiother. 2018 May 25. pii: S1278-3218(18)30074-X. doi: 10.1016/j.canrad.2017.11.006. [Epub ahead of print]

PMID:
29776830
7.

Long-term Outcome of a Fissurectomy: A Prospective Single-Arm Study of 50 Operations out of 349 Initial Patients.

Zeitoun JD, Blanchard P, Fathallah N, Benfredj P, Lemarchand N, de Parades V.

Ann Coloproctol. 2018 Apr;34(2):83-87. doi: 10.3393/ac.2017.06.12. Epub 2018 Apr 30.

8.

Comparing Intensity-Modulated Proton Therapy With Intensity-Modulated Photon Therapy for Oropharyngeal Cancer: The Journey From Clinical Trial Concept to Activation.

Frank SJ, Blanchard P, Lee JJ, Sturgis EM, Kies MS, Machtay M, Vikram B, Garden AS, Rosenthal DI, Gunn GB, Fuller CD, Hutcheson K, Lai S, Busse PM, Lee NY, Lin A, Foote RL.

Semin Radiat Oncol. 2018 Apr;28(2):108-113. doi: 10.1016/j.semradonc.2017.12.002. Review.

PMID:
29735186
9.

Direct (Hetero)Arylation Polymerization of a Spirobifluorene and a Dithienyl-Diketopyrrolopyrrole Derivative: New Donor Polymers for Organic Solar Cells.

Josse P, Dayneko S, Zhang Y, Dabos-Seignon S, Zhang S, Blanchard P, Welch GC, Cabanetos C.

Molecules. 2018 Apr 20;23(4). pii: E962. doi: 10.3390/molecules23040962.

10.

Treatment de-escalation for HPV-driven oropharyngeal cancer: Where do we stand?

Mirghani H, Blanchard P.

Clin Transl Radiat Oncol. 2017 Nov 4;8:4-11. doi: 10.1016/j.ctro.2017.10.005. eCollection 2018 Jan. Review.

11.

Prognostic impact of leukocyte counts before and during radiotherapy for oropharyngeal cancer.

Jensen GL, Blanchard P, Gunn GB, Garden AS, David Fuller C, Sturgis EM, Gillison ML, Phan J, Morrison WH, Rosenthal DI, Frank SJ.

Clin Transl Radiat Oncol. 2017 Nov 6;7:28-35. doi: 10.1016/j.ctro.2017.09.008. eCollection 2017 Dec.

12.

Nedaplatin in nasopharyngeal cancer: the rebirth of platinum salts?

Blanchard P, Tao Y.

Lancet Oncol. 2018 Apr;19(4):429-431. doi: 10.1016/S1470-2045(18)30113-X. Epub 2018 Feb 28. No abstract available.

PMID:
29501364
13.

Parapoxviral vulvovaginitis in Holstein cows.

Moeller RB Jr, Crossley B, Adaska JM, Hsia G, Kahn R, Blanchard PC.

J Vet Diagn Invest. 2018 May;30(3):464-467. doi: 10.1177/1040638718758829. Epub 2018 Feb 11.

PMID:
29429402
14.

Thienylene vinylene dimerization: from solution to self-assembled monolayer on gold.

Bkhach S, Alévêque O, Blanchard P, Gautier C, Levillain E.

Nanoscale. 2018 Jan 25;10(4):1613-1616. doi: 10.1039/c7nr07238d.

PMID:
29327013
15.

Multicenter Randomized Double-Blind, Placebo-Controlled Trial GORTEC (Groupe Oncologie Radiotherapie Tete et Cou) 2009-01 Evaluating the Effect of the Regenerating Agent on Radiodermatitis of Head and Neck Cancer Patients.

Tao Y, Auperin A, Sire C, Martin M, Saliou MG, Bardet E, Sun XS, Chatellier T, Morand C, Cornely A, Angokai M, Di Rito A, Kichenin K, Blanchard P, D'Onofrio I, Bourhis J.

Int J Radiat Oncol Biol Phys. 2017 Nov 1;99(3):590-595. doi: 10.1016/j.ijrobp.2017.07.019. Epub 2017 Jul 22.

PMID:
29280453
16.

Patient-reported health-related quality of life for men treated with low-dose-rate prostate brachytherapy as monotherapy with 125-iodine, 103-palladium, or 131-cesium: Results of a prospective phase II study.

Blanchard P, Pugh TJ, Swanson DA, Mahmood U, Chen HC, Wang X, Graber WJ, Kudchadker RJ, Bruno T, Feeley T, Frank SJ.

Brachytherapy. 2018 Mar - Apr;17(2):265-276. doi: 10.1016/j.brachy.2017.11.007. Epub 2017 Dec 18.

PMID:
29269207
17.

Anemia and neutrophil-to-lymphocyte ratio are prognostic in p16-positive oropharyngeal carcinoma treated with concurrent chemoradiation.

Gorphe P, Chekkoury Idrissi Y, Tao Y, Schernberg A, Ou D, Temam S, Casiraghi O, Blanchard P, Mirghani H.

Papillomavirus Res. 2018 Jun;5:32-37. doi: 10.1016/j.pvr.2017.12.002. Epub 2017 Dec 11.

18.

A randomized trial of induction docetaxel-cisplatin-5FU followed by concomitant cisplatin-RT versus concomitant cisplatin-RT in nasopharyngeal carcinoma (GORTEC 2006-02).

Frikha M, Auperin A, Tao Y, Elloumi F, Toumi N, Blanchard P, Lang P, Sun S, Racadot S, Thariat J, Alfonsi M, Tuchais C, Cornely A, Moussa A, Guigay J, Daoud J, Bourhis J; GORTEC.

Ann Oncol. 2018 Mar 1;29(3):731-736. doi: 10.1093/annonc/mdx770.

PMID:
29236943
19.

Prospective Phase 2 Trial of Permanent Seed Implantation Prostate Brachytherapy for Intermediate-Risk Localized Prostate Cancer: Efficacy, Toxicity, and Quality of Life Outcomes.

Frank SJ, Pugh TJ, Blanchard P, Mahmood U, Graber WJ, Kudchadker RJ, Davis JW, Kim J, Choi H, Troncoso P, Kuban DA, Choi S, McGuire S, Hoffman KE, Chen HC, Wang X, Swanson DA.

Int J Radiat Oncol Biol Phys. 2018 Feb 1;100(2):374-382. doi: 10.1016/j.ijrobp.2017.09.050. Epub 2017 Oct 12.

20.

Proton Therapy for Head and Neck Cancers.

Blanchard P, Gunn GB, Lin A, Foote RL, Lee NY, Frank SJ.

Semin Radiat Oncol. 2018 Jan;28(1):53-63. doi: 10.1016/j.semradonc.2017.08.004. Review.

PMID:
29173756
21.

Prognostic impact of HPV-associated p16-expression and smoking status on outcomes following radiotherapy for oropharyngeal cancer: The MARCH-HPV project.

Lassen P, Lacas B, Pignon JP, Trotti A, Zackrisson B, Zhang Q, Overgaard J, Blanchard P; MARCH Collaborative Group.

Radiother Oncol. 2018 Jan;126(1):107-115. doi: 10.1016/j.radonc.2017.10.018.

PMID:
29100700
22.

Long-term evaluation of urinary, sexual, and quality of life outcomes after brachytherapy for penile carcinoma.

Gambachidze D, Lebacle C, Maroun P, Escande A, Bossi A, Blanchard P, Deutsch E, Haie-Meder C, Chargari C.

Brachytherapy. 2018 Jan - Feb;17(1):221-226. doi: 10.1016/j.brachy.2017.09.006. Epub 2017 Oct 28.

PMID:
29089276
23.

Prognostic value of tissue necrosis, hypoxia-related markers and correlation with HPV status in head and neck cancer patients treated with bio- or chemo-radiotherapy.

Ou D, Garberis I, Adam J, Blanchard P, Nguyen F, Levy A, Casiraghi O, Gorphe P, Breuskin I, Janot F, Temam S, Scoazec JY, Deutsch E, Tao Y.

Radiother Oncol. 2018 Jan;126(1):116-124. doi: 10.1016/j.radonc.2017.10.007. Epub 2017 Nov 1.

PMID:
29079308
24.

Reciprocal Genetics: Identifying QTL for General and Specific Combining Abilities in Hybrids Between Multiparental Populations from Two Maize (Zea mays L.) Heterotic Groups.

Giraud H, Bauland C, Falque M, Madur D, Combes V, Jamin P, Monteil C, Laborde J, Palaffre C, Gaillard A, Blanchard P, Charcosset A, Moreau L.

Genetics. 2017 Nov;207(3):1167-1180. doi: 10.1534/genetics.117.300305. Epub 2017 Sep 28.

25.

X-Rays from the Location of the Double-humped Transient ASASSN-15lh.

Margutti R, Metzger BD, Chornock R, Milisavljevic D, Berger E, Blanchard PK, Guidorzi C, Migliori G, Kamble A, Lunnan R, Nicholl M, Coppejans DL, Dall'Osso S, Drout MR, Perna R, Sbarufatti B.

Astrophys J. 2017 Feb 10;836(1). pii: 25. doi: 10.3847/1538-4357/836/1/25. Epub 2017 Feb 6.

26.

Linkage Analysis and Association Mapping QTL Detection Models for Hybrids Between Multiparental Populations from Two Heterotic Groups: Application to Biomass Production in Maize (Zea mays L.).

Giraud H, Bauland C, Falque M, Madur D, Combes V, Jamin P, Monteil C, Laborde J, Palaffre C, Gaillard A, Blanchard P, Charcosset A, Moreau L.

G3 (Bethesda). 2017 Nov 6;7(11):3649-3657. doi: 10.1534/g3.117.300121.

27.

Quality of life after brachytherapy or bilateral nerve-sparing robot-assisted radical prostatectomy for prostate cancer: a prospective cohort.

Blanchard P, Davis JW, Frank SJ, Kim J, Pettaway CA, Pugh TJ, Pisters LL, Ward JF, Choi S, Chapin BF, Hoffman K, Navai N, Achim M, McGuire SE, Matin SF, Nguyen Q, Mahmood U, Graber WJ, Chen HC, Wang X, Kuban DA.

BJU Int. 2018 Apr;121(4):540-548. doi: 10.1111/bju.14021. Epub 2017 Oct 17.

PMID:
28941030
28.

In Regard to Sher et al.

Walker GV, Blanchard P, Garden AS.

Pract Radiat Oncol. 2018 Jan - Feb;8(1):66-67. doi: 10.1016/j.prro.2017.07.013. Epub 2017 Aug 5. No abstract available.

PMID:
28939352
29.

Clinical relevance of tumor infiltrating lymphocytes, PD-L1 expression and correlation with HPV/p16 in head and neck cancer treated with bio- or chemo-radiotherapy.

Ou D, Adam J, Garberis I, Blanchard P, Nguyen F, Levy A, Casiraghi O, Gorphe P, Breuskin I, Janot F, Temam S, Scoazec JY, Deutsch E, Tao Y.

Oncoimmunology. 2017 Jul 5;6(9):e1341030. doi: 10.1080/2162402X.2017.1341030. eCollection 2017.

30.

[A randomized controlled trial of metastases-directed treatment in patients with metastatic prostate cancer using stereotactic body irradiation: A GETUG-AFU trial].

Blanchard P, Foulon S, Louvel G, Habibian M, Fizazi K.

Cancer Radiother. 2017 Oct;21(6-7):491-494. doi: 10.1016/j.canrad.2017.06.007. Epub 2017 Aug 30. French.

PMID:
28869198
31.

[Proton therapy for head and neck cancers].

Blanchard P, Frank SJ.

Cancer Radiother. 2017 Oct;21(6-7):515-520. doi: 10.1016/j.canrad.2017.06.008. Epub 2017 Aug 30. Review. French.

PMID:
28869195
32.

Burnout among young European oncologists: a call for action.

Blanchard P.

Ann Oncol. 2017 Jul 1;28(7):1414-1415. doi: 10.1093/annonc/mdx256. No abstract available.

PMID:
28863448
33.

Neutrophils, a candidate biomarker and target for radiation therapy?

Schernberg A, Blanchard P, Chargari C, Deutsch E.

Acta Oncol. 2017 Nov;56(11):1522-1530. doi: 10.1080/0284186X.2017.1348623. Epub 2017 Aug 23. Review.

PMID:
28835188
34.

Radiation therapy to the primary in metastatic prostate cancer: palliation only or altering tumor biology?

Blanchard P, Bossi A, Fizazi K.

Curr Opin Urol. 2017 Nov;27(6):580-586. doi: 10.1097/MOU.0000000000000444. Review.

PMID:
28816713
35.

Thermally induced crystallization, hole-transport, NLO and photovoltaic activity of a bis-diarylamine-based push-pull molecule.

Jiang Y, Allain M, Gindre D, Dabos-Seignon S, Blanchard P, Cabanetos C, Roncali J.

Sci Rep. 2017 Aug 16;7(1):8317. doi: 10.1038/s41598-017-08606-6.

36.

Radiation-induced neurocognitive dysfunction in head and neck cancer patients.

De Felice F, Blanchard P.

Tumori. 2017 Jul 31;103(4):319-324. doi: 10.5301/tj.5000678. Epub 2017 Jul 25. Review.

PMID:
28762462
37.

Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis.

Lacas B, Bourhis J, Overgaard J, Zhang Q, Grégoire V, Nankivell M, Zackrisson B, Szutkowski Z, Suwiński R, Poulsen M, O'Sullivan B, Corvò R, Laskar SG, Fallai C, Yamazaki H, Dobrowsky W, Cho KH, Beadle B, Langendijk JA, Viegas CMP, Hay J, Lotayef M, Parmar MKB, Aupérin A, van Herpen C, Maingon P, Trotti AM, Grau C, Pignon JP, Blanchard P; MARCH Collaborative Group.

Lancet Oncol. 2017 Sep;18(9):1221-1237. doi: 10.1016/S1470-2045(17)30458-8. Epub 2017 Jul 27. Erratum in: Lancet Oncol. 2018 Apr;19(4):e184.

38.

Clinical outcomes after interstitial brachytherapy for early-stage nasal squamous cell carcinoma.

Bacorro W, Escande A, Temam S, Dumas I, Routier E, Gensse MC, Blanchard P, Janot F, Mateus C, Tao Y, Robert C, Deutsch E, Haie-Meder C, Chargari C.

Brachytherapy. 2017 Sep - Oct;16(5):1021-1027. doi: 10.1016/j.brachy.2017.06.009. Epub 2017 Jul 23.

PMID:
28743612
39.

Whole-Genome Sequencing and Concordance Between Antimicrobial Susceptibility Genotypes and Phenotypes of Bacterial Isolates Associated with Bovine Respiratory Disease.

Owen JR, Noyes N, Young AE, Prince DJ, Blanchard PC, Lehenbauer TW, Aly SS, Davis JH, O'Rourke SM, Abdo Z, Belk K, Miller MR, Morley P, Van Eenennaam AL.

G3 (Bethesda). 2017 Sep 7;7(9):3059-3071. doi: 10.1534/g3.117.1137.

40.

Predictive and prognostic value of CT based radiomics signature in locally advanced head and neck cancers patients treated with concurrent chemoradiotherapy or bioradiotherapy and its added value to Human Papillomavirus status.

Ou D, Blanchard P, Rosellini S, Levy A, Nguyen F, Leijenaar RTH, Garberis I, Gorphe P, Bidault F, Ferté C, Robert C, Casiraghi O, Scoazec JY, Lambin P, Temam S, Deutsch E, Tao Y.

Oral Oncol. 2017 Aug;71:150-155. doi: 10.1016/j.oraloncology.2017.06.015. Epub 2017 Jun 26.

PMID:
28688683
41.

Outcomes of multimodal management for sinonasal squamous cell carcinoma.

Paré A, Blanchard P, Rosellini S, Aupérin A, Gorphe P, Casiraghi O, Temam S, Bidault F, Page P, Kolb F, Janot F, Moya Plana A.

J Craniomaxillofac Surg. 2017 Aug;45(8):1124-1132. doi: 10.1016/j.jcms.2017.05.006. Epub 2017 May 12.

PMID:
28601297
42.

Intensity-modulated proton therapy and osteoradionecrosis in oropharyngeal cancer.

Zhang W, Zhang X, Yang P, Blanchard P, Garden AS, Gunn B, Fuller CD, Chambers M, Hutcheson KA, Ye R, Lai SY, Radwan MAS, Zhu XR, Frank SJ.

Radiother Oncol. 2017 Jun;123(3):401-405. doi: 10.1016/j.radonc.2017.05.006. Epub 2017 May 23.

43.

Permanent prostate brachytherapy postimplant magnetic resonance imaging dosimetry using positive contrast magnetic resonance imaging markers.

Martin GV, Pugh TJ, Mahmood U, Kudchadker RJ, Wang J, Bruno TL, Bathala T, Blanchard P, Frank SJ.

Brachytherapy. 2017 Jul - Aug;16(4):761-769. doi: 10.1016/j.brachy.2017.04.004. Epub 2017 May 10.

44.

Brachytherapy for Conservative Treatment of Invasive Penile Carcinoma: Prognostic Factors and Long-Term Analysis of Outcome.

Escande A, Haie-Meder C, Mazeron R, Maroun P, Cavalcanti A, de Crevoisier R, Schernberg A, Marsolat F, Blanchard P, Martinetti F, Bossi A, Dumas I, Deutsch E, Chargari C.

Int J Radiat Oncol Biol Phys. 2017 Nov 1;99(3):563-570. doi: 10.1016/j.ijrobp.2017.02.090. Epub 2017 Feb 28.

PMID:
28501419
45.

ECOG-ACRIN 1308: Commentary on a Negative Phase II Trial.

Garden AS, Blanchard P.

J Clin Oncol. 2017 Jun 10;35(17):1969-1970. doi: 10.1200/JCO.2017.72.5085. Epub 2017 Apr 21. No abstract available.

PMID:
28430528
46.

Outbreaks of bovine herpesvirus 2 infections in calves causing ear and facial skin lesions.

Watanabe TTN, Moeller RB Jr, Crossley BM, Blanchard PC.

J Vet Diagn Invest. 2017 Sep;29(5):686-690. doi: 10.1177/1040638717704480. Epub 2017 Apr 19.

PMID:
28423989
47.

[Management of a progressing prostate cancer: results of a national study].

Rozet F, Roupret M, Hennequin C, Massard C, Blanchard P, Le Moulec S.

Prog Urol. 2017 May;27(6):381-388. doi: 10.1016/j.purol.2017.02.001. Epub 2017 Apr 6. French.

PMID:
28392429
48.

Is there an increased risk of cancer among spouses of patients with an HPV-related cancer: A systematic review.

Mirghani H, Sturgis EM, Aupérin A, Monsonego J, Blanchard P.

Oral Oncol. 2017 Apr;67:138-145. doi: 10.1016/j.oraloncology.2017.02.024. Epub 2017 Feb 28. Review.

PMID:
28351568
49.

Enantiopure versus Racemic Naphthalimide End-Capped Helicenic Non-fullerene Electron Acceptors: Impact on Organic Photovoltaics Performance.

Josse P, Favereau L, Shen C, Dabos-Seignon S, Blanchard P, Cabanetos C, Crassous J.

Chemistry. 2017 May 5;23(26):6277-6281. doi: 10.1002/chem.201701066. Epub 2017 Apr 10.

PMID:
28301059
50.

Agreement Among 4 Sampling Methods to Identify Respiratory Pathogens in Dairy Calves with Acute Bovine Respiratory Disease.

Doyle D, Credille B, Lehenbauer TW, Berghaus R, Aly SS, Champagne J, Blanchard P, Crossley B, Berghaus L, Cochran S, Woolums A.

J Vet Intern Med. 2017 May;31(3):954-959. doi: 10.1111/jvim.14683. Epub 2017 Mar 14.

Supplemental Content

Loading ...
Support Center